Sandra Garcet
Rockefeller University(US)
Publications by Year
Research Areas
Dermatology and Skin Diseases, Psoriasis: Treatment and Pathogenesis, Asthma and respiratory diseases, Hidradenitis Suppurativa and Treatments, Allergic Rhinitis and Sensitization
Most-Cited Works
- → Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: A randomized, double-blind, phase 2a trial(2018)330 cited
- → Efficacy and safety of ustekinumab treatment in adults with moderate‐to‐severe atopic dermatitis(2016)214 cited
- → An Integrated Model of Atopic Dermatitis Biomarkers Highlights the Systemic Nature of the Disease(2016)206 cited
- → Baseline IL-22 expression in patients with atopic dermatitis stratifies tissue responses to fezakinumab(2018)191 cited
- → Age-specific changes in the molecular phenotype of patients with moderate-to-severe atopic dermatitis(2019)136 cited
- → Phase 2a randomized clinical trial of dupilumab (anti‐IL‐4Rα) for alopecia areata patients(2021)133 cited
- → Epithelialized tunnels are a source of inflammation in hidradenitis suppurativa(2021)122 cited
- → Autoantigens ADAMTSL5 and LL37 are significantly upregulated in active Psoriasis and localized with keratinocytes, dendritic cells and other leukocytes(2017)113 cited
- → The effect of subcutaneous brodalumab on clinical disease activity in hidradenitis suppurativa: An open-label cohort study(2020)111 cited
- → Nonlesional atopic dermatitis skin shares similar T‐cell clones with lesional tissues(2017)83 cited